Pharmaceutical Sector

AstraZeneca’s acquisition will make lot of sense for Pfizer: says analyst

The recently published report about Pfizer's supposed interest in British drugmaker AstraZeneca has prompted many experts to predict that such a deal would make a lot of sense for the U. S. pharmaceuticals giant.

Companies: 
General: 

Pfizer interested in AstraZeneca: report

American pharmaceuticals giant Pfizer Inc is reportedly mulling a plan to place a bid for struggling British drugs-maker AstraZeneca.

General: 
Companies: 

Reckitts Troubled Pharmaceutical Arm Posts Better –than-expected Sales Figures

Reckitt Benckiser the makers of Dettol and Durex condoms yesterday hinted towards follow-on of its pharmaceuticals arm that was much in trouble earlier. This happened as it posted a sales figure during the fourth quarter that was better than what was actually expected out of it.

General: 
Companies: 

GSK the UK drug company faces charges for bribing Polish doctors

GlaxoSmithKline which is the largest drug company of UK supposedly bribed some doctors and now is going through a criminal investigation case in Poland, BBC Panorama has revealed.

Today some fresh evidences revealed that the money which was used for bribing was supposed to be spent on educating patients.

Companies: 
General: 

Sanofi finally wins Genzyme deal

Ending months of uncertainty, the Sanofi-Aventis deal with Genzyme finally came to an end since Sanofit was able to buy out Genzyme for $74 per share. This means that a total of $20.1 billion is going to be given as contingent value right and will bring to a halt the nine months of chase of the US biotech firm by French drugs' giant.

It is going to help Sanofi in controlling the falling revenues that are a result of several of its patents expiring and the cost that it has to bear for reshaping its business.

General: 

Pages

Subscribe to RSS - Pharmaceutical Sector